1.孙宇昕，魏芬芳，杨悦. 真实世界证据用于药械监管与卫生决策的机遇与挑战. 中国药物警戒，2017,14（6）:353-358. 2.吴一龙，陈晓媛，杨志敏等（吴阶平医学基金会，中国胸部肿瘤研究协作组）. 真实世界研究指南. 2018. 3.中共中央办公厅，国务院办公厅. 关于深化审评审批制度改革鼓励药品医疗器械创新的意见. 2017. 4.ADAPTABLE Investigators. Aspirin Dosing: a Patient-Centric Trial Assessing Benefits and Long-Term Effectiveness （ADAPTABLE）study protocol. http://pcornet. org/wp-content/uploads/2015 /06/ADAPTABLE-Protocol-Final-Draft-6-4-15_for-post_06-26-. pdf[J]. Published June，2015，5. 5.Berger M，Daniel G，Frank K，et al. A frame work for regulatory use of real-world evidence[J]. White paper prepared by the Duke Margolis Center for Health Policy,2017,6. 6.Cave A，Kurz X，Arlett P. Real-world data for regulatory decision making: challenges and possible solutions for europe[J]. Clinical pharmacology and therapeutics，2019，106（1）: 36. 7.Dreyer NA. Advancing a framework for regulatory use of real-world evidence: when real is reliable[J]. Therapeutic innovation & regulatory science，2018，52（3）: 362-368. 8.Egger M，Moons K G M，Fletcher C，et al. GetReal: from efficacy in clinical trials to relative effectiveness in the real world[J]. Research synthesis methods，2016，7（3）: 278-281. 9.Ford I，Norrie J. Pragmatic trials[J]. N Engl J Med，2016，375（5）: 454-463. 10.Institute of Medicine 2009. Initial national priorities for comparative effectiveness research. Washington，DC: The National Academies Press. https://doi.org/10.17226/12648. 11.James S. Importance of post-approval real-word evidence[J]. European Heart Journal-Cardiovascular Pharmacotherapy，2018; 4（1）:10-11. 12.Kohl S. Joint HMA/EMA task force on big data established[J]. Eur J Hosp Pharm，2017，24（3）: 180-190. 13.Lash TL，Fox MP，Fink AK. Applying quantitative bias analysis to epidemiologic data[M]. Springer Science & Business Media，2011. 14.Makady A，de Boer A，Hillege H，et al. What is real-world data? A review of definitions based on literature and stakeholder interviews[J]. Value in health，2017，20（7）: 858-865. 15.Olariu E，Papageorgakopoulou C，Bovens S M，et al. Real world evidence in Europe: a snapshot of its current status[J]. Value in Health，2016，19（7）: A498. 16.Roland M，Torgerson D J. Understanding controlled trials: What are pragmatic trials?[J]. BMJ，1998，316（7127）: 285. 17.Sherman RE，Anderson SA，Dal Pan GJ，et al. Real-world evidence—what is it and what can it tell us[J]. N Engl J Med，2016，375（23）: 2293-2297. 18.Sugarman J，Califf RM. Ethics and regulatory complexities for pragmatic clinical trials[J]. JAMA，2014，311（23）: 2381-2382. 19.US Food and Drug Administration. Framework for FDA’s real-world evidence program. December 2018[J]. 2019. 20.Velentgas P，Dreyer NA，Nourjah P，Smith SR，Torchia MM，eds. Developing a Protocol for Observational Comparative Effectiveness Research: A User’s Guide. AHRQ Publication No. 12（13）-EHC099. Rockville，MD: Agency for Healthcare Research and Quality; January 2013. www.effectivehealthcare.ahrq.gov/ Methods-OCER.cfm. 21.Von Elm E，Altman D G，Egger M，et al. The Strengthening the Reporting of Observational Studies in Epidemiology （STROBE）statement: guidelines for reporting observational studies[J]. Annals of internal medicine，2007，147（8）: 573-577.
附录：1.真实世界研究有关词汇表 2.真实世界证据应用示例 3.真实世界研究常用统计分析方法 4.真实世界研究有关中英文词汇对照 |
